Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biofrontera (BFRI) Change in Account Payables: 2024-2025

Historic Change in Account Payables for Biofrontera (BFRI) over the last 2 years, with Sep 2025 value amounting to $1.3 million.

  • Biofrontera's Change in Account Payables fell 5.93% to $1.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.8 million, marking a year-over-year change of. This contributed to the annual value of -$1.5 million for FY2024, which is 133.11% down from last year.
  • Biofrontera's Change in Account Payables amounted to $1.3 million in Q3 2025, which was up 166.46% from -$2.0 million recorded in Q2 2025.
  • Biofrontera's Change in Account Payables' 5-year high stood at $1.4 million during Q3 2024, with a 5-year trough of -$2.7 million in Q1 2025.
  • For the 2-year period, Biofrontera's Change in Account Payables averaged around -$687,143, with its median value being -$1.6 million (2024).
  • Data for Biofrontera's Change in Account Payables shows a maximum YoY slumped of 47.62% (in 2025) over the last 5 years.
  • Quarterly analysis of 2 years shows Biofrontera's Change in Account Payables stood at $585,000 in 2024, then declined by 5.93% to $1.3 million in 2025.
  • Its Change in Account Payables stands at $1.3 million for Q3 2025, versus -$2.0 million for Q2 2025 and -$2.7 million for Q1 2025.